FDA Inspection 1003878 — Seaway Pharma Inc.

Seaway Pharma Inc. — FEI 3012275336

The FDA completed an inspection of Seaway Pharma Inc. on March 1, 2017 in Massena, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 1, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Massena, NY (United States)